Results 201 to 210 of about 79,383 (224)

Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study. [PDF]

open access: yesInflamm Bowel Dis
Sands BE   +18 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

PRIMA-1MET Synergizes With Cisplatin to Induce Tumor Cell Apoptosis

Oncogene, 2005
Klas Wiman   +2 more
exaly  

Home - About - Disclaimer - Privacy